Malasía - enska - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

idaman pharma manufacturing sdn bhd - sulphamethoxazole; trimethoprim -

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - poliovirus, quantity: 17 dagu; poliovirus, quantity: 20 dagu; poliovirus, quantity: 5 dagu - injection, suspension - excipient ingredients: sodium hydroxide; hydrochloric acid; formaldehyde solution; phenoxyethanol; glucose monohydrate; purified water; polysorbate 80; ascorbic acid; sodium chloride; aminobenzoic acid; adenosine phosphate; dl-alpha-tocopheryl phosphate disodium; magnesium sulfate; monobasic potassium phosphate; deoxyribose; calcium chloride dihydrate; iron trinitrate; potassium chloride; magnesium sulfate heptahydrate; potassium nitrate; sodium selenite; monobasic sodium phosphate; dibasic sodium phosphate heptahydrate; adenine sulfate; adenosine triphosphate disodium; cholesterol; glutathione; guanine hydrochloride; hypoxanthine; phenolsulfonphthalein; ribose; sodium acetate; thymine; uracil; xanthine; sodium pyruvate; dl-alanine; arginine hydrochloride; dl-aspartic acid; cysteine hydrochloride; cystine dihydrochloride; dl-glutamic acid; glutamine; glycine; histidine hydrochloride; hydroxyproline; isoleucine; asparagine; dl-leucine; lysine hydrochloride; dl-methionine; dl-phenylalanine; proline; dl-serine; - ipol is indicated for active immunisation of infants, children and adults for the prevention of poliomyelitis. ipol should be offered to patients who have refused opv or in whom opv is contraindicated. ipol is also indicated for: 1) the primary vaccination of immunocompromised individuals of all ages, and household contacts of such individuals (when vaccination is indicated); (2) unvaccinated or inadequately vaccinated(*) adults, particularly if at increased risk of exposure to live polio virus, including: - travellers to areas or countries where poliomyelitis is epidemic or endemic: - laboratory workers handling specimens which may contain polio virus; - health care workers in close contact with patients who may be excreting polioviruses. (*) such as those who may not have completed a primary series of vaccination or not received a booster dose since infancy. idications as at 9 june 2003: ipol is indicated for active immunisation of infants, children and adults for the prevention of poliomyelitis. recommen

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - hepatitis a virus antigen, quantity: 320 agu/ml - injection, suspension - excipient ingredients: neomycin; polysorbate 80; formaldehyde; aluminium hydroxide hydrate; phenoxyethanol; hydrochloric acid; sodium hydroxide; ethanol absolute; glucose monohydrate; ascorbic acid; sodium chloride; calcium chloride dihydrate; ferric nitrate nonahydrate; potassium chloride; magnesium sulfate heptahydrate; monobasic potassium phosphate; dibasic sodium phosphate; adenine sulfate dihydrate; adenosine triphosphate disodium; adenosine phosphate; cholesterol; deoxyribose; glutathione; guanine hydrochloride monohydrate; sodium hypoxanthine; ribose; sodium acetate; thymine; uracil; sodium xanthine; dl-alanine; arginine hydrochloride; dl-aspartic acid; cysteine hydrochloride; cystine dihydrochloride; dl-glutamic acid; glutamine; glycine; histidine hydrochloride; isoleucine; hydroxyproline; dl-leucine; lysine hydrochloride; dl-methionine; dl-phenylalanine; proline; dl-serine; dl-threonine; dl-tryptophan; tyrosine disodium; dl-valine; biotin; ergocalciferol; calcium pantothenate; choline chloride; folic acid; inositol; menadione; nicotinic acid; nicotinamide; aminobenzoic acid; pyridoxal hydrochloride; pyridoxine hydrochloride; riboflavine; thiamine hydrochloride; retinol acetate; dl-alpha-tocopheryl phosphate disodium - avaxim is indicated for: active immunisation against hepatitis a infections in adults and children 2 years and older who are or will be at increased risk of infection: - travellers to areas of moderate or high endemicity for hepatitis a. - visitors to rural and remote indigenous communities. - child day-care and pre-school personnel. - the intellectually disabled and their carers. -health care providers. - sewerage workers. - men who have sex with men. - injecting drug users. - patients with chronic liver disease. - haemophiliacs who may receive pooled plasma concentrates.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - hepatitis a virus antigen, quantity: 160 elisa unit - injection, suspension - excipient ingredients: neomycin; formaldehyde; bovine serum albumin; polysorbate 80; aluminium hydroxide hydrate; phenoxyethanol; glucose monohydrate; ascorbic acid; sodium chloride; calcium chloride dihydrate; ferric nitrate nonahydrate; potassium chloride; magnesium sulfate heptahydrate; monobasic potassium phosphate; dibasic sodium phosphate; adenine sulfate dihydrate; adenosine triphosphate disodium; adenosine phosphate; cholesterol; deoxyribose; glutathione; guanine hydrochloride monohydrate; sodium hypoxanthine; ribose; sodium acetate; thymine; uracil; sodium xanthine; dl-alanine; arginine hydrochloride; dl-aspartic acid; cysteine hydrochloride; cystine dihydrochloride; dl-glutamic acid; glutamine; glycine; histidine hydrochloride; isoleucine; hydroxyproline; dl-leucine; lysine hydrochloride; dl-methionine; dl-phenylalanine; proline; dl-serine; dl-threonine; dl-tryptophan; tyrosine disodium; dl-valine; biotin; ergocalciferol; calcium pantothenate; choline chloride; folic acid; inositol; menadione; nicotinic acid; nicotinamide; aminobenzoic acid; pyridoxal hydrochloride; pyridoxine hydrochloride; riboflavine; thiamine hydrochloride; retinol acetate; dl-alpha-tocopheryl phosphate disodium - vivaxim is indicated for simultaneous active immunisation against typhoid fever and hepatitis a virus infections in subject's aged 16 and older.

Sviss - franska - Swissmedic (Swiss Agency for Therapeutic Products)

verfora sa - dl-methioninum, cystinum, acidum 4-aminobenzoicum, thiaminum, pyridoxinum, acidum pantothenicum, calcii pantothenas, milii extractum, tritici embryonis extractum, faex medicinalis siccata, ferrum, iron(ii) amino acid chelate, zincum, cuprum - capsules - dl-methioninum 100 mg, cystinum 50 mg, acide 4-aminobenzoicum 20 mg, thiaminum 1.34 mg à thiamini hydrochloridum, pyridoxinum 8.2 mg à pyridoxini hydrochloridum, de l'acide d-pantothenicum 45,8 mg de calcium pantothenas 50 mg, millet moyenne de 50 mg d'extrait de blé embryonis 50 mg d'extrait, faex médicinales siccata 50 mg, fer à 2 mg, zinc 2 mg, cuivre 0.5 mg, color.: e 104, e 132, excipiens pro de la capsule. - troubles de croissance des cheveux et des ongles - synthetika

Sviss - þýska - Swissmedic (Swiss Agency for Therapeutic Products)

verfora sa - dl-methioninum, cystinum, acidum 4-aminobenzoicum, thiaminum, pyridoxinum, acidum pantothenicum, calcii pantothenas, milii extractum, tritici embryonis extractum, faex medicinalis siccata, ferrum, iron(ii) amino acid chelate, zincum, cuprum - kapseln - dl-methioninum 100 mg, cystinum 50 mg, säure 4-aminobenzoicum 20 mg, thiaminum 1.34 mg bis thiamini hydrochloridum, pyridoxinum 8.2 mg bis pyridoxini hydrochloridum, säure d-pantothenicum 45.8 mg calcium pantothenas 50 mg, hirse bedeuten-extrakt 50 mg, weizen embryonis-extrakt 50 mg, faex medizinische siccata 50 mg, eisen 2 mg, zink 2 mg, kupfer 0,5 mg, color.: e 104, e 132, excipiens pro kapsel. - wachstumsstörungen der haare und nägel - synthetika

Taívan - kínverska - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

勝達有限公司 台北巿龍江路２３５號８Ｆ之２ (11704809) - para-aminobenzoic acid (vit h1) - （粉） - 主成分 () ; para-aminobenzoic acid (vit h1) (8813200104) - 抗日晒劑

Taívan - kínverska - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

東信化學藥品有限公司 台北巿吉林路４５號６樓 (11328755) - para-aminobenzoic acid (vit h1) - （粉） - 主成分 () ; para-aminobenzoic acid (vit h1) (8813200104) 99.5-101.0% - 拉立克次體、斑疹、傷寒病原體

Taívan - kínverska - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

勝達有限公司 台北巿龍江路２３５號８Ｆ之２ (11704809) - para-aminobenzoic acid (vit h1) - （粉） - 主成分 () ; para-aminobenzoic acid (vit h1) (8813200104) 98.5+% - 抗日晒劑

Brasilía - portúgalska - ANVISA (Agência Nacional de Vigilância Sanitária)

biolab sanus farmacÊutica ltda - pantotenato de cÁlcio, cistina, nitrato de tiamina, levedura, queratina, Ácido aminobenzÓico - outros prods nao enquadrados em classe terapeutica especif